Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Clinical trial NCT01362517 · COMPLETED
Trial details
- NCT number
- NCT01362517
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-07-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.